 ImmuCell NASDAQ: ICCC is one of 25 public companies in the Diagnostic substances industry, but how does it contrast to its peers? We will compare ImmuCell to related companies based on the strength of its dividends, earnings, profitability, risk, analyst recommendations, institutional ownership and valuation. Analyst Ratings This is a breakdown of current ratings and ... 